Technology News and Research

RSS

Accurate Flow Measurement Helps Reduce Drug Production Costs

The Atrato and MetraFlow ultrasonic flowmeters from Titan Enterprises have been designed to enable drug manufacturers to streamline production and reduce costs. These devices measure the rate of flow of fluids with extraordinary levels of accuracy, helping drug manufacturers control small details that make a big difference during production.

From Titan Enterprises Ltd 15 Jan 2021

New DNA test quickly identifies secondary infections in COVID-19 patients

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.

15 Jan 2021

Study may lead to novel synthetic drugs to combat bacterial infections

Researchers at the Technion – Israel Institute of Technology and EMBL Hamburg have discovered remarkable molecular properties of an antimicrobial peptide from the skin of the Australian toadlet. The discovery could inspire the development of novel synthetic drugs to combat bacterial infections.

15 Jan 2021

New method uses artificial intelligence to map intestinal bacteria using feces

The intestines and their bacteria are sometimes called our ’second brain’, but studying these bacteria in their natural environment is difficult. Now researchers from the University of Copenhagen have developed a method that uses artificial intelligence to map intestinal bacteria using feces.

15 Jan 2021

Study offers a differentiated patient-specific solution in minimal residual disease testing

Exact Sciences Corp. today announced that it has acquired a worldwide exclusive license to the proprietary TARDIS technology from the Translational Genomics Research Institute (TGen), an affiliate of City of Hope.

15 Jan 2021

Highly sensitive technique helps measure the extent of cytoskeleton bundling

A research group from Kumamoto University, Japan has developed a highly sensitive technique to quantitatively evaluate the extent of cytoskeleton bundling from microscopic images. Until now, analysis of cytoskeleton organization was generally made by manually checking microscopic images.

14 Jan 2021

Stem cells with regenerative abilities could be closer on the horizon, shows study

A new type of stem cell - that is, a cell with regenerative abilities - could be closer on the horizon, a new study led by UNSW Sydney shows.

14 Jan 2021

Excess COVID-19 deaths in overwhelmed Israeli hospitals

Researchers in Israel have conducted a study showing that increased hospital load due to rising coronavirus disease 2019 (COVID-19) cases resulted in higher COVID-19-related mortality, despite hospitals not exceeding their defined threshold for meeting patients' treatment needs.

14 Jan 2021

Researchers develop a tiny, yet effective method for preventing premature birth

In a study in mice and human cells, Johns Hopkins Medicine researchers say that they have developed a tiny, yet effective method for preventing premature birth.

13 Jan 2021

Novel compound appears to protect myelin and nerve fibers

A compound developed at Oregon Health & Science University appears to protect nerve fibers and the fatty sheath, called myelin, that covers nerve cells in the brain and spinal cord.

13 Jan 2021

Moderna to develop three new mRNA-based vaccines against HIV, influenza, and the Nipah virus

Morderna has announced plans to develop a range of new mRNA-based vaccines against other viruses, including the influenza virus, human immunodeficiency virus (HIV), and the Nipah virus.

13 Jan 2021

Hospitals’ rocky rollout of covid vaccine sparks questions of fairness

Last week, after finishing inoculations of some front-line hospital staff, Jupiter Medical Center was left with 40 doses of precious covid vaccine. So, officials offered shots to the South Florida hospital’s board of directors and their spouses over age 65.

13 Jan 2021

Researchers produce lightweight grab-poles with anti-microbial property for public transport

Since the beginning of the Covid-19 pandemic many people have been, or may feel, hesitant about taking public transport, due to the perceived risk of picking up germs from areas such as the grab-poles on trains, buses and trams, which are the principal point of contact.

13 Jan 2021

Axol Bioscience strengthens commercial leadership team with key appointments

Axol Bioscience today announced the appointment of Ross Wheatcroft as the Global Strategic Accounts Manager.

From Axol Bioscience Ltd 13 Jan 2021

New technology could protect against different coronavirus variants

The SARS-CoV-2 virus that is causing the COVID-19 pandemic is just one of many different viruses in the coronavirus family.

13 Jan 2021

New technology helps study muscle biology more clearly

Exercising regularly is one of the best defenses against metabolic diseases, such as obesity and diabetes - but why? It's a question that scientists are still struggling to answer. While exercising changes the molecular behavior of muscles, it's not well understood how these molecular changes improve metabolic health.

13 Jan 2021

New publication describes DiosCURE’s multivalent single-chain antibodies to inactivate SARS-CoV-2

DiosCURE SE announced a publication in Science describing its core technology of multivalent single-chain antibodies with a unique molecular mode-of-action to inactivate SARS-CoV-2 virions. An international team led by scientists at the University of Bonn developed and characterized the lead candidates, which are exclusively licensed by DiosCURE.

13 Jan 2021

Renowned experts challenge conventional wisdom across the imaging community

A special issue of the Journal of the American College of Radiology (JACR), published by Elsevier, challenges conventional wisdom across the imaging community.

13 Jan 2021

Hypoxia signaling pathway could lead to COVID-19 treatments

Researchers in Spain have demonstrated that studying the hypoxia signaling pathway could provide opportunities for treating coronavirus disease 2019 (COVID-19).

12 Jan 2021

Leading pediatric hospital reveals top AI models in COVID-19 Grand Challenge

The top 10 results have been unveiled in the first-of-its-kind COVID-19 Lung CT Lesion Segmentation Grand Challenge, a groundbreaking research competition focused on developing artificial intelligence (AI) models to help in the visualization and measurement of COVID specific lesions in the lungs of infected patients, potentially facilitating to more timely and patient-specific medical interventions.

12 Jan 2021